Jackson Acquisition Co II Files 8-K

Ticker: JACS-RI · Form: 8-K · Filed: Dec 17, 2024 · CIK: 2039058

Jackson Acquisition CO II 8-K Filing Summary
FieldDetail
CompanyJackson Acquisition CO II (JACS-RI)
Form Type8-K
Filed DateDec 17, 2024
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.0001, $10.00, $230,000,000, $8,400,000, $232,300,000
Sentimentneutral

Sentiment: neutral

Topics: spac, reporting, 8-k

TL;DR

Jackson Acquisition Co II filed an 8-K on Dec 17 for events on Dec 11. Standard reporting.

AI Summary

Jackson Acquisition Company II, a blank check company, filed an 8-K on December 17, 2024, reporting an event on December 11, 2024. The filing pertains to 'Other Events' and 'Financial Statements and Exhibits'. The company's principal executive offices are located at 2655 Northwinds Parkway, Alpharetta, GA 30009.

Why It Matters

This 8-K filing indicates Jackson Acquisition Company II is providing updates on its corporate activities and financial reporting, which is standard for publicly traded companies.

Risk Assessment

Risk Level: low — This filing is a routine 8-K for a SPAC, indicating standard corporate reporting rather than a significant event.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Jackson Acquisition Company II?

The 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of December 11, 2024, and was filed on December 17, 2024.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on December 11, 2024.

What is the principal executive office address for Jackson Acquisition Company II?

The principal executive office address is 2655 Northwinds Parkway, Alpharetta, GA 30009.

What is the SIC code for Jackson Acquisition Company II?

The Standard Industrial Classification (SIC) code for Jackson Acquisition Company II is 6770, which corresponds to Blank Checks.

What is the filing date of this 8-K report?

This 8-K report was filed on December 17, 2024.

Filing Stats: 749 words · 3 min read · ~2 pages · Grade level 11.1 · Accepted 2024-12-17 16:15:24

Key Financial Figures

Filing Documents

01 Other Events

Item 8.01 Other Events. On December 11, 2024, Jackson Acquisition Company II (the “ Company ”) consummated its initial public offering (the “ IPO ”) of 20,000,000 units (the “ Units ”). In connection with the closing, the underwriter fully exercised its over-allotment option to purchase 3,000,000 additional Units (the “ OA Option ”) for an aggregate of 23,000,000 Units sold. Each Unit consists of one Class A ordinary share, par value $0.0001 per share (“ Class A Ordinary Share ”), of the Company and one right to acquire one-tenth (1/10) of one Class A ordinary share (the “ Rights ”). The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000. Simultaneously with the closing of the IPO, the Company completed the private sale of an aggregate of 840,000 private placement units (the “ Private Placement Units ”) to RJ Healthcare SPAC II, LLC, and Roth Capital Partners, LLC at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $8,400,000. The Private Placement Units are identical to the Units sold in the IPO and OA Option, subject to certain limited exceptions, and will be subject to transfer restrictions until 30 days following the consummation of the Company’s initial business combination. The Private Placement Units were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, as the transactions did not involve a public offering. A total of $232,300,000, comprised of proceeds from the IPO and the sale of the Private Placement Units, were placed into a segregated trust account located in the United States with Continental Stock Transfer & Trust Company acting as trustee. An audited balance sheet as of December 11, 2024 reflecting receipt of the proceeds upon consummation of the IPO and the sale of the Private Placement Units has been issued by the Company and i

01 Financial Statement and Exhibits

Item 9.01 Financial Statement and Exhibits. (d) Exhibits. The following exhibits are filed with this Form 8-K: Exhibit No. Description of Exhibits 99.1 Audited Balance Sheet, as of December 11, 2024. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Jackson Acquisition Company II Date: December 17, 2024 By: /s/ Richard L. Jackson Name: Richard L. Jackson Title: Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing